Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post... see more

TSXV:LBL.H - Post Discussion

Lattice Biologics Ltd > I'm very confident that LBL
View:
Post by MaterialWorld on Apr 07, 2020 6:03pm

I'm very confident that LBL

share price is undervalued. I picked up another 50,000 shares today @ 0.135 cents per share. In my world, that price was a gift. Before you know it, we'll be north of .20 cents Who knows what other countries other than the USA that Guy has been in contact with that will aprove AmnioBoost to fight COVID-19. Things are starting to happen. Like I said before, Guy is no fool. We've got cash on hand and trials have started. Hold tight folks, tomorrow's another day.     MW
Comment by DigitalSpurs on Apr 07, 2020 6:08pm
Well said MW, Absolutely agree!! Hopefully Guy lets us know what the next steps are now, how many people signed up to enrol and potentially other countries that have started to enrol. Very exciting time to be here!
Comment by Unicorn9000 on Apr 07, 2020 9:07pm
prepare to lose 50%. scary stuff very very scary
Comment by Lazer23 on Apr 07, 2020 10:02pm
IMPORTANT RISK FACTORS ASSOCIATED WITH LATTICE BIOLOGICS Our business is at an early stage of development and we may not develop therapeutic products that can be commercialized. It's written in plain English.... Even if it works... Be careful....  I will not post here again, unless I get back in... GLTA
Comment by wintrader on Apr 07, 2020 11:12pm
I agree with you MW !!  Share price will keep rising up over the next coming days ... LBL didn't get 6 million for fun from Alumina ! We didn't have over 11 million shares traded today for fun  !! Follow the smart money and you can't go wrong ! “We are thrilled to invest in Lattice as they embark upon Phase I trials of AmnioBoost,” said Adi Nahmani, Managing Member of ...more  
Comment by MaterialWorld on Apr 08, 2020 6:35am
Your right on wintrader. Putting it another way, Alumina is'nt handing over 6 Million dollars because they know it's a bad deal. Also, Alumina is taking shares in exchange for it's cash, why ?? because they know share price is going to go down. Don't think so. Believe me, Guy must have gave information to Alumina that you and I are not privy to at this point. Something is up, big ...more  
Comment by MaterialWorld on Apr 08, 2020 11:38am
Buy on the dips. I was just gifted more shares @ 0.125 cents. This is the calm before the storm folks. Guy and Alumina are in this thing to win.  So am I.       GLTA         MW 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities